Cellulitis: Diagnosis and management

Dermatologic Therapy

Volumn 24, Issue 2, 2011, Pages 229-239

  Elizabeth, Bailey ^a   Daniela, Kroshinsky ^b  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cellulitis; Diagnosis; Erysipelas; Hospitalized patient; Treatment

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; CEFALEXIN; CEFAZOLIN; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DICLOXACILLIN; DOXYCYCLINE; GRANULOCYTE COLONY STIMULATING FACTOR; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; NAFCILLIN; OXACILLIN; PENICILLIN G; PENICILLIN V; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULTAMICILLIN; UNINDEXED DRUG; VANCOMYCIN;

ANAMNESIS; ANTIBIOTIC THERAPY; ARTICLE; BITE; CAT BITE; CELLULITIS; CLINICAL FEATURE; CONTACT DERMATITIS; DEEP VEIN THROMBOSIS; DERMATOMYCOSIS; DIABETIC FOOT; DIAGNOSTIC ACCURACY; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DOG BITE; DRUG CHOICE; DRUG ERUPTION; ERYSIPELAS; ERYTHEMA; ERYTHEMA CHRONICUM MIGRANS; HUMAN; LABORATORY TEST; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; ONYCHOMYCOSIS; PANNICULITIS; PHYSICAL EXAMINATION; SKIN BIOPSY; SKIN BLOOD VESSEL DISORDER; TINEA PEDIS; VENOUS STASIS; VENOUS STASIS DERMATITIS; VIRAL SKIN DISEASE;

ANTI-BACTERIAL AGENTS; CELLULITIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; PREDICTIVE VALUE OF TESTS; SKIN; TREATMENT OUTCOME;

EID: 79952767001     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2011.01398.x     Document Type: Article

References (42)

1. Christensen KL, Holman RC, Steiner CA, Sejvar JJ, Stoll BJ, Schonberger LB. Infectious disease hospitalizations in the United States. Clin Infect Dis 2009: 49: 1025-1035.
2. Hersh AL, Chambers HF, Maselli JH, Gonzales R. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med 2008: 168: 1585-1591.
3. Hepburn MJ, Dooley DP, Ellis MW. Alternative diagnoses that often mimic cellulitis. Am Fam Physician 2003: 67: 2471. (Pubitemid 36773309)
4. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005: 41: 1373-1406.
5. Fontes RA, Jr, Ogilvie CM, Miclau T. Necrotizing soft-tissue infections. J Am Acad Orthop Surg 2000: 8: 151-158.
6. Cox NH. Oedema as a risk factor for multiple episodes of cellulitis/erysipelas of the lower leg: a series with community follow-up. Br J Dermatol 2006: 155: 947-950. (Pubitemid 44564503)
7. Dupuy A, Benchikhi H, Roujeau JC, et al. Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ 1999: 318: 1591-1594. (Pubitemid 29267772)
8. Binswanger IA, Kral AH, Bluthenthal RN, Rybold DJ, Edlin BR. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis 2000: 30: 579-581. (Pubitemid 30205308)
9. Brewer VH, Hahn KA, Rohrbach BW, Bell JL, Baddour LM. Risk factor analysis for breast cellulitis complicating breast conservation therapy. Clin Infect Dis 2000: 31: 654-659. (Pubitemid 32295481)
10. Karakas M, Baba M, Aksungur VL, et al. Manifestation of cellulitis after saphenous venectomy for coronary bypass surgery. J Eur Acad Dermatol Venereol 2002: 16: 438-440. (Pubitemid 35174333)
11. Bagnari V, Colina M, Ciancio G, Govoni M, Trotta F. Adult-onset still's disease. Rheumatol Int 2010: 30: 855-862.
12. Kroshinsky D, Grossman ME, Fox LP. Approach to the patient with presumed cellulitis. Semin Cutan Med Surg 2007: 26: 168-178. (Pubitemid 350216509)
13. Wald ER. Periorbital and orbital infections. Infect Dis Clin North Am 2007: 21: 393-408. (Pubitemid 46874826)
14. Givner LB. Periorbital versus orbital cellulitis. Pediatr Infect Dis J 2002: 21: 1157-1158. (Pubitemid 35463034)
15. Bergan JJ, Schmid-Schonbein GW, Smith PD, Nicolaides AN, Boisseau MR, Eklof B. Chronic venous disease. N Engl J Med 2006: 355: 488-498. (Pubitemid 44162276)
16. Raju S, Neglen P. Clinical practice. Chronic venous insufficiency and varicose veins. N Engl J Med 2009: 360: 2319-2327.
17. Weaver J, Billings SD. Initial presentation of stasis dermatitis mimicking solitary lesions: a previously unrecognized clinical scenario. J Am Acad Dermatol 2009: 61: 1028-1032.
18. Clark SC, Zirwas MJ. Management of occupational dermatitis. Dermatol Clin 2009: 27: 365-383. vii-viii.
19. Antezana M, Parker F. Occupational contact dermatitis. Immunol Allergy Clin North Am 2003: 23: 269-290. vii.
20. Falagas ME, Vergidis PI. Narrative review: diseases that masquerade as infectious cellulitis. Ann Intern Med 2005: 142: 47-55. (Pubitemid 40066213)
21. Belsito DV. Occupational contact dermatitis: etiology, prevalence, and resultant impairment/disability. J Am Acad Dermatol 2005: 53: 303-313. (Pubitemid 40979588)
22. Tan M, van Rooden CJ, Westerbeek RE, Huisman MV. Diagnostic management of clinically suspected acute deep vein thrombosis. Br J Haematol 2009: 146: 347-360.
23. Baker WF, Jr. Diagnosis of deep venous thrombosis and pulmonary embolism. Med Clin North Am 1998: 82: 459-476.
24. Wells PS, Hirsh J, Anderson DR, et al. Accuracy of clinical assessment of deep-vein thrombosis. Lancet 1995: 345: 1326-1330.
25. Penaloza A, Laureys M, Wautrecht JC, Lheureux P, Motte S. Accuracy and safety of pretest probability assessment of deep vein thrombosis by physicians in training using the explicit Wells clinical model. J Thromb Haemost 2006: 4: 278-281.
26. Bates SM, Ginsberg JS. Clinical practice. Treatment of deep-vein thrombosis. N Engl J Med 2004: 351: 268-277.
27. Requena L, Yus ES. Erythema nodosum. Dermatol Clin 2008: 26: 425-438. v.
28. Mert A, Ozaras R, Tabak F, Pekmezci S, Demirkesen C, Ozturk R. Erythema nodosum: an experience of 10 years. Scand J Infect Dis 2004: 36: 424-427. (Pubitemid 39089190)
29. Marques AR. Lyme disease: a review. Curr Allergy Asthma Rep 2010: 10: 13-20.
30. Wormser GP. Clinical practice. Early Lyme disease. N Engl J Med 2006: 354: 2794-2801. (Pubitemid 43974197)
31. Wormser GP, Nadelman RB, Dattwyler RJ, et al. Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America. Clin Infect Dis 2000: 31 (Suppl. 1): 1-14.
32. Hook EW, 3rd, Hooton TM, Horton CA, Coyle MB, Ramsey PG, Turck M. Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med 1986: 146: 295-297. (Pubitemid 16018547)
33. Perl B, Gottehrer NP, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM. Cost-effectiveness of blood cultures for adult patients with cellulitis. Clin Infect Dis 1999: 29: 1483-1488. (Pubitemid 30022745)
34. Weedon D. Skin pathology, 2nd ed. New York: Churchill Livingston, 2002.
35. Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002: 34: 730-751. (Pubitemid 34194843)
36. Pineda C, Vargas A, Rodriguez AV. Imaging of osteomyelitis: current concepts. Infect Dis Clin North Am 2006: 20: 789-825. (Pubitemid 44802782)
37. Struk DW, Munk PL, Lee MJ, Ho SG, Worsley DF. Imaging of soft tissue infections. Radiol Clin North Am 2001: 39: 277-303. (Pubitemid 32295247)
38. Boucher HW, Corey GR. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008: 46 (Suppl. 5): S344-S349. (Pubitemid 351717321)
39. Cohen PR. Community-acquired methicillin-resistant Staphylococcus aureus skin infections: a review of epidemiology, clinical features, management, and prevention. Int J Dermatol 2007: 46: 1-11. (Pubitemid 46029718)
40. Swartz MN. Clinical practice. Cellulitis. N Engl J Med 2004: 350: 904-912.
41. Bonnetblanc JM, Bedane C. Erysipelas: recognition and management. Am J Clin Dermatol 2003: 4: 157-163. (Pubitemid 36390472)
42. Hedrick J. Acute bacterial skin infections in pediatric medicine: current issues in presentation and treatment. Paediatr Drugs 2003: 5 (Suppl. 1): 35-46. (Pubitemid 37082991)